Doliver Advisors, LP Abbott Laboratories Transaction History

Doliver Advisors, LP

$346 Million
Q3 2024

A detailed history of Doliver Advisors, LP transactions in Abbott Laboratories stock. As of the latest transaction made, Doliver Advisors, LP holds 13,531 shares of ABT stock, worth $1.58 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

13,531

Previous 13,153 2.87%

Holding current value

$1.58 Million

Previous $1.37 Million 12.88%

% of portfolio

0.45%

Previous 0.39%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	BUY	$100.07 - $118.13 $37,826 - $44,653	378 Added 2.87%	13,531 $1.54 Million
Q2 2024 Jul 12, 2024	BUY	$100.73 - $112.44 $110,903 - $123,796	1,101 Added 9.14%	13,153 $1.37 Million
Q1 2024 Apr 12, 2024	SELL	$109.52 - $120.96 $63,193 - $69,793	-577 Reduced 4.57%	12,052 $1.37 Million
Q4 2023 Jan 03, 2024	BUY	$90.19 - $110.4 $4,058 - $4,968	45 Added 0.36%	12,629 $1.39 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $17,864 - $21,433	-187 Reduced 1.46%	12,584 $1.22 Million
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $16,931 - $18,864	168 Added 1.33%	12,771 $1.39 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $88,433 - $104,091	-913 Reduced 6.75%	12,603 $1.28 Million
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $570 - $669	-6 Reduced 0.04%	13,516 $1.48 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $796,625 - $922,342	8,233 Added 155.66%	13,522 $1.31 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $60,731 - $73,405	595 Added 12.68%	5,289 $575,000
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $22,804 - $27,808	200 Added 4.45%	4,694 $556,000
Q4 2021 Feb 07, 2022	SELL	$115.53 - $141.46 $325,332 - $398,351	-2,816 Reduced 38.52%	4,494 $583,000
Q3 2021 Nov 03, 2021	SELL	$116.66 - $129.06 $302,149 - $334,265	-2,590 Reduced 26.16%	7,310 $864,000
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $1.26 Million - $1.48 Million	-11,924 Reduced 54.64%	9,900 $1.15 Million
Q1 2021 May 07, 2021	BUY	$108.84 - $128.23 $62,583 - $73,732	575 Added 2.71%	21,824 $2.62 Million
Q4 2020 Feb 04, 2021	BUY	$105.0 - $114.42 $474,495 - $517,063	4,519 Added 27.01%	21,249 $2.33 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $900,454 - $1.09 Million	9,826 Added 142.32%	16,730 $1.82 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $1,148 - $1,470	-15 Reduced 0.22%	6,904 $631,000
Q4 2019 Jan 27, 2020	SELL	$78.51 - $87.4 $1,805 - $2,010	-23 Reduced 0.33%	6,919 $601,000
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $27,825 - $30,171	-340 Reduced 4.67%	6,942 $569,000
Q2 2019 Jul 25, 2019	SELL	$72.88 - $85.0 $34,982 - $40,800	-480 Reduced 6.18%	7,282 $612,000
Q4 2018 Jan 31, 2019	SELL	$65.56 - $74.27 $9,637 - $10,917	-147 Reduced 1.86%	7,762 $561,000
Q1 2018 May 08, 2018	BUY	$56.27 - $63.62 $81,085 - $91,676	1,441 Added 22.28%	7,909 $0
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $13,420 - $14,367	-250 Reduced 3.72%	6,468 $369,000
Q3 2017 Nov 03, 2017	BUY	$48.06 - $53.64 $322,867 - $360,353	6,718	6,718 $358,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doliver Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Doliver Advisors, LP with notifications on news.

Account

Doliver Advisors, LP Abbott Laboratories Transaction History